T1	Participants 71 118	patients with poorly controlled type 2 diabetes
T2	Participants 195 231	patients with type 2 diabetes (T2DM)
T3	Participants 258 411	multinational, open-label trial included subjects treated for T2DM with metformin ± sulphonylurea, who had glycated haemoglobin (HbA1c) levels of 7.5-12%
T4	Participants 735 950	The mean [standard deviation (s.d.)] age of the participants was 57 (9) years, the duration of diabetes was 9 (6) years, body mass index was 31.9 (4.2) kg/m(2) and HbA1c level was 9.0 (1.1)%. Equal numbers (n = 489)
T5	Participants 1837 1873	subjects with poorly controlled T2DM
